ID C8AP2_HUMAN Reviewed; 1982 AA. AC Q9UKL3; A2RUB7; Q6PH76; Q7LCQ7; Q86YD9; Q9NUQ4; Q9NZV9; Q9P2N1; AC Q9Y563; DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 05-OCT-2010, entry version 63. DE RecName: Full=CASP8-associated protein 2; DE AltName: Full=FLICE-associated huge protein; GN Name=CASP8AP2; Synonyms=FLASH, KIAA1315, RIP25; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=T-cell; RA Kimura T., Imai Y., Yonehara S.; RT "Reply: searching for FLASH domains."; RL Nature 401:662-663(1999). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Peripheral blood leukocyte; RA Yan M.D., Sun L.Y., Liu X.Y., Zheng Z.C.; RT "RIP25, a human homolog of Mus musculus FLASH, is involved in IL-2 RT signaling."; RL Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX MEDLINE=20181126; PubMed=10718198; DOI=10.1093/dnares/7.1.65; RA Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XVI. RT The complete sequences of 150 new cDNA clones from brain which code RT for large proteins in vitro."; RL DNA Res. 7:65-73(2000). RN [4] RP SEQUENCE REVISION. RX MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99; RA Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.; RT "Construction of expression-ready cDNA clones for KIAA genes: manual RT curation of 330 KIAA cDNA clones."; RL DNA Res. 9:99-106(2002). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Skin, and Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1478-1982. RC TISSUE=Placenta; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] OF 714-1982. RX MEDLINE=20005496; PubMed=10537104; DOI=10.1038/44317; RA Koonin E.V., Aravind L., Hofmann K., Tschopp J., Dixit V.M.; RT "Apoptosis. Searching for FLASH domains."; RL Nature 401:662-662(1999). RN [9] RP FUNCTION, INTERACTION WITH NCOA2, SUBCELLULAR LOCATION, AND INDUCTION. RX PubMed=12477726; DOI=10.1074/jbc.M209234200; RA Kino T., Chrousos G.P.; RT "Tumor necrosis factor alpha receptor- and Fas-associated FLASH RT inhibit transcriptional activity of the glucocorticoid receptor by RT binding to and interfering with its interaction with p160 type nuclear RT receptor coactivators."; RL J. Biol. Chem. 278:3023-3029(2003). RN [10] RP FUNCTION, AND INTERACTION WITH NCOA3. RX PubMed=15698540; DOI=10.1016/j.jsbmb.2004.09.003; RA Kino T., Ichijo T., Chrousos G.P.; RT "FLASH interacts with p160 coactivator subtypes and differentially RT suppresses transcriptional activity of steroid hormone receptors."; RL J. Steroid Biochem. Mol. Biol. 92:357-363(2004). RN [11] RP FUNCTION, INTERACTION WITH NPAT, AND SUBCELLULAR LOCATION. RX PubMed=17003125; DOI=10.1073/pnas.0604227103; RA Barcaroli D., Bongiorno-Borbone L., Terrinoni A., Hofmann T.G., RA Rossi M., Knight R.A., Matera A.G., Melino G., De Laurenzi V.; RT "FLASH is required for histone transcription and S-phase RT progression."; RL Proc. Natl. Acad. Sci. U.S.A. 103:14808-14812(2006). RN [12] RP UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-92 AND LYS-93, AND MASS RP SPECTROMETRY. RC TISSUE=Mammary cancer; RX PubMed=17370265; DOI=10.1002/pmic.200600410; RA Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; RT "Tryptic digestion of ubiquitin standards reveals an improved strategy RT for identifying ubiquitinated proteins by mass spectrometry."; RL Proteomics 7:868-874(2007). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1278, AND MASS RP SPECTROMETRY. RC TISSUE=Embryonic kidney; RX PubMed=17525332; DOI=10.1126/science.1140321; RA Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, RA Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., RA Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; RT "ATM and ATR substrate analysis reveals extensive protein networks RT responsive to DNA damage."; RL Science 316:1160-1166(2007). RN [14] RP INTERACTION WITH CASP8AP2. RX PubMed=19546234; DOI=10.1128/MCB.00289-09; RA Kiriyama M., Kobayashi Y., Saito M., Ishikawa F., Yonehara S.; RT "Interaction of FLASH with arsenite resistance protein 2 is involved RT in cell cycle progression at S phase."; RL Mol. Cell. Biol. 29:4729-4741(2009). CC -!- FUNCTION: Participates in TNF-alpha-induced blockade of CC glucocorticoid receptor (GR) transactivation at the nuclear CC receptor coactivator level, upstream and independently of NF- CC kappa-B. Suppresses both NCOA2- and NCOA3-induced enhancement of CC GR transactivation. Involved in TNF-alpha-induced activation of CC NF-kappa-B via a TRAF2-dependent pathway. Acts as a downstream CC mediator for CASP8-induced activation of NF-kappa-B. Required for CC the activation of CASP8 in FAS-mediated apoptosis. Required for CC histone gene transcription and progression through S phase. CC -!- SUBUNIT: Self-associates. Component of the death-inducing CC signaling complex (DISC) with CASP8, FADD and FAS. Interacts with CC NCOA2, NCOA3, SRRT/ARS2 and TRAF2. Interacts with NPAT. CC -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Localizes to CC discrete nuclear foci. CC -!- INDUCTION: By TNF which induces strong nuclear localization. CC -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR. CC -!- SEQUENCE CAUTION: CC Sequence=AAH56685.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 364; CC Sequence=BAA92067.1; Type=Erroneous initiation; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF154415; AAF03367.1; -; mRNA. DR EMBL; AF164678; AAD45537.2; -; mRNA. DR EMBL; AB037736; BAA92553.2; -; mRNA. DR EMBL; CH471051; EAW48540.1; -; Genomic_DNA. DR EMBL; CH471051; EAW48542.1; -; Genomic_DNA. DR EMBL; BC042577; AAH42577.1; -; mRNA. DR EMBL; BC056685; AAH56685.1; ALT_SEQ; mRNA. DR EMBL; BC132828; AAI32829.1; -; mRNA. DR EMBL; BC132830; AAI32831.1; -; mRNA. DR EMBL; AK002070; BAA92067.1; ALT_INIT; mRNA. DR EMBL; AF165161; AAD45157.1; -; mRNA. DR IPI; IPI00100798; -. DR RefSeq; NP_001131139.1; -. DR RefSeq; NP_001131140.1; -. DR RefSeq; NP_036247.1; -. DR UniGene; Hs.558218; -. DR ProteinModelPortal; Q9UKL3; -. DR SMR; Q9UKL3; 1914-1979. DR IntAct; Q9UKL3; 2. DR MINT; MINT-91616; -. DR STRING; Q9UKL3; -. DR PhosphoSite; Q9UKL3; -. DR PRIDE; Q9UKL3; -. DR Ensembl; ENST00000455594; ENSP00000391210; ENSG00000118412. DR GeneID; 9994; -. DR KEGG; hsa:9994; -. DR UCSC; uc003pnt.1; human. DR CTD; 9994; -. DR GeneCards; GC06P090539; -. DR H-InvDB; HIX0006071; -. DR HGNC; HGNC:1510; CASP8AP2. DR HPA; CAB010396; -. DR MIM; 606880; gene. DR PharmGKB; PA26093; -. DR HOVERGEN; HBG080371; -. DR InParanoid; Q9UKL3; -. DR NextBio; 37755; -. DR ArrayExpress; Q9UKL3; -. DR Bgee; Q9UKL3; -. DR CleanEx; HS_CASP8AP2; -. DR Genevestigator; Q9UKL3; -. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0008656; F:caspase activator activity; ISS:UniProtKB. DR GO; GO:0005123; F:death receptor binding; TAS:ProtInc. DR GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB. DR GO; GO:0006919; P:activation of caspase activity; ISS:UniProtKB. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0008625; P:induction of apoptosis via death domain rec...; ISS:UniProtKB. DR GO; GO:0007165; P:signal transduction; TAS:ProtInc. DR GO; GO:0006350; P:transcription; IEA:UniProtKB-KW. DR InterPro; IPR009057; Homeodomain-like. DR SUPFAM; SSF46689; Homeodomain_like; 1. PE 1: Evidence at protein level; KW Activator; Apoptosis; Cell cycle; Complete proteome; Cytoplasm; KW Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism; Repressor; KW Transcription; Transcription regulation; Ubl conjugation. FT CHAIN 1 1982 CASP8-associated protein 2. FT /FTId=PRO_0000076188. FT REGION 1709 1982 NCOA2-binding. FT MOD_RES 1278 1278 Phosphoserine. FT CROSSLNK 92 92 Glycyl lysine isopeptide (Lys-Gly) FT (interchain with G-Cter in ubiquitin). FT CROSSLNK 93 93 Glycyl lysine isopeptide (Lys-Gly) FT (interchain with G-Cter in ubiquitin). FT VARIANT 1659 1659 P -> S (in dbSNP:rs3799896). FT /FTId=VAR_050700. FT CONFLICT 278 278 L -> S (in Ref. 2; AAD45537). FT CONFLICT 362 362 D -> E (in Ref. 6; AAH56685). FT CONFLICT 638 638 L -> P (in Ref. 2; AAD45537). FT CONFLICT 668 668 M -> T (in Ref. 2; AAD45537). FT CONFLICT 861 861 N -> S (in Ref. 2; AAD45537). FT CONFLICT 1713 1713 C -> Y (in Ref. 2; AAD45537). FT CONFLICT 1754 1754 Missing (in Ref. 3; BAA92553). FT CONFLICT 1832 1832 S -> P (in Ref. 7; BAA92067). SQ SEQUENCE 1982 AA; 222658 MW; AF2B1A7798C19E39 CRC64; MAADDDNGDG TSLFDVFSAS PLKNNDEGSL DIYAGLDSAV SDSASKSCVP SRNCLDLYEE ILTEEGTAKE ATYNDLQVEY GKCQLQMKEL MKKFKEIQTQ NFSLINENQS LKKNISALIK TARVEINRKD EEISNLHQRL SEFPHFRNNH KTARTFDTVK TKDLKSRSPH LDDCSKTDHR AKSDVSKDVH HSTSLPNLEK EGKPHSDKRS TSHLPTSVEK HCTNGVWSRS HYQVGEGSSN EDSRRGRKDI RHSQFNRGTE RVRKDLSTGC GDGEPRILEA SQRLQGHPEK YGKGEPKTES KSSKFKSNSD SDYKGERINS SWEKETPGER SHSRVDSQSD KKLERQSERS QNINRKEVKS QDKEERKVDQ KPKSVVKDQD HWRRSERASL PHSKNEITFS HNSSKYHLEE RRGWEDCKRD KSVNSHSFQD GRCPSSLSNS RTHKNIDSKE VDAMHQWENT PLKAERHRTE DKRKREQESK EENRHIRNEK RVPTEHLQKT NKETKKTTTD LKKQNEPKTD KGEVLDNGVS EGADNKELAM KAESGPNETK NKDLKLSFMK KLNLTLSPAK KQPVSQDNQH KITDIPKSSG VCDSESSMQV KTVAYVPSIS EHILGEAAVS EHTMGETKST LLEPKVALLA VTEPRIGISE TNKEDENSLL VRSVDNTMHC EEPICGTETS FPSPMEIQQT ESLFPSTGMK QTINNGRAAA PVVMDVLQTD VSQNFGLELD TKRNDNSDYC GISEGMEMKV ALSTTVSETT ESILQPSIEE ADILPIMLSE DNNPKFEPSV IVTPLVESKS CHLEPCLPKE TLDSSLQQTE LMDHRMATGE TNSVYHDDDN SVLSIDLNHL RPIPEAISPL NSPVRPVAKV LRNESPPQVP VYNNSHKDVF LPNSAHSTSK SQSDLNKENQ KPIYKSDKCT EADTCKNSPL DELEEGEIRS DSETSKPQES FEKNSKRRVS ADVRKSKTIP RRGKSTVCLD KDSRKTHVRI HQTNNKWNKR PDKSSRSSKT EKKDKVMSTS SLEKIVPIIA VPSSEQEIMH MLRMIRKHVR KNYMKFKAKF SLIQFHRIIE SAILSFTSLI KHLNLHKISK SVTTLQKNLC DIIESKLKQV KKNGIVDRLF EQQLPDMKKK LWKFVDDQLD YLFAKLKKIL VCDSKSFGRD SDEGKLEKTS KQNAQYSNSQ KRSVDNSNRE LLKEKLSKSE DPVHYKSLVG CKKSEENYQD QNNSSINTVK HDIKKNFNIC FDNIKNSQSE ERSLEVHCPS TPKSEKNEGS SIEDAQTSQH ATLKPERSFE ILTEQQASSL TFNLVSDAQM GEIFKSLLQG SDLLDSSVNC TEKSEWELKT PEKQLLETLK CESIPACTTE ELVSGVASPC PKMISDDNWS LLSSEKGPSL SSGLSLPVHP DVLDESCMFE VSTNLPLSKD NVCSVEKSKP CVSSILLEDL AVSLTVPSPL KSDGHLSFLK PDMSSSSTPE EVISAHFSED ALLEEEDASE QDIHLALESD NSSSKSSCSS SWTSRSVAPG FQYHPNLPMH AVIMEKSNDH FIVKIRRATP STSSGLKQSM MPDELLTSLP RHGKEADEGP EKEYISCQNT VFKSVEELEN SNKNVDGSKS THEEQSSMIQ TQVPDIYEFL KDASDKMGHS DEVADECFKL HQVWETKVPE SIEELPSMEE ISHSVGEHLP NTYVDLTKDP VTETKNLGEF IEVTVLHIDQ LGCSGGNLNQ SAQILDNSLQ ADTVGAFIDL TQDASSEAKS EGNHPALAVE DLGCGVIQVD EDNCKEEKAQ VANRPLKCIV EETYIDLTTE SPSSCEVKKD ELKSEPGSNC DNSELPGTLH NSHKKRRNIS DLNHPHKKQR KETDLTNKEK TKKPTQDSCE NTEAHQKKAS KKKAPPVTKD PSSLKATPGI KDSSAALATS TSLSAKNVIK KKGEIIILWT RNDDREILLE CQKRGPSFKT FAYLAAKLDK NPNQVSERFQ QLMKLFEKSK CR //